4:05 PM ET
10-Q
Financial Results
Orchestra BioMed Holdings Q3 2026 Results: Net Loss of $18.8M, Loss Narrows
Orchestra BioMed reported a significant decrease in total revenue to $0.29 million for the nine months ended September 30, 2026, compared to $2.57 million in the prior year, primarily due to the absence of partnership revenue. The company's total stockholders' equity declined from $53.6 million to $7.8 million as the accumulated deficit reached $425.8 million.
- Key figure
- Net loss $18.8M